Timeline of the Current Shortages
Abbott Closes Sturgis, MI Plant
Selected formulas are part of a voluntary recall and the plant, which manufacturers all of Abbott’s metabolic products, is closed.
Medical Community Mobilizes
Metabolic RDs & patient groups convene to address shortage
By a coaltion of organizations affected by the shortages.
Abbott’s Urgent Release Program initiated
Enabling access to metabolic products manufactured prior to the closing of the Sturgis plant.
Due to flooding caused by rainstorms
Coram/CVS metabolic discontinuations
Reducing access to more than 50 metabolic products
Sturgis reopens again
Speciality and metabolic products are given priority in the reopening plan
Abbott restarts manufacture of metabolic products
Loose timelines provided for release, starting in September
Release Dates Shift
Abbott announces some metabolic products won’t be released until as late as January 2023
Release dates shift again
Release dates for more products shifted to November, December and January 2023